TNGX
NASDAQ · Biotechnology
Tango Therapeutics Inc
$19.48
+0.52 (+2.74%)
Open$18.75
Previous Close$18.96
Day High$19.75
Day Low$18.51
52W High$13.48
52W Low$1.03
Volume—
Avg Volume2.57M
Market Cap1.66B
P/E Ratio—
EPS$-0.92
SectorBiotechnology
Analyst Ratings
Strong Buy
17 analysts
Price Target
+45.0% upside
Current
$19.48
$19.48
Target
$28.24
$28.24
$22.54
$28.24 avg
$42.65
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 51.46M | 49.32M | 421.41M |
| Net Income | -159,365,892 | -137,463,391 | -114,600,480 |
| Profit Margin | -309.7% | -294.2% | -27.2% |
| EBITDA | -165,711,671 | -150,877,982 | -127,773,532 |
| Free Cash Flow | — | — | -89,915,808 |
| Rev Growth | +4.3% | +4.3% | +7.1% |
| Debt/Equity | — | — | 0.61 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |